Company: NCEL
Filing Date: 2025-05-16
Form Type: 20-F
Source: 0001213900-25-044868
Chunk: 41

Company: NewcelX Ltd.
Filing Date: 2025-05-16
Form: 20-F
Item: Item 3
Chunk 41
---
 Consequently, we may not be able to seek to prevent third parties from practicing our inventions in all countries outside
the United States and Switzerland, or from selling or importing products made using our inventions in and into the United States or other
jurisdictions. Competitors, for example, may use our technologies in jurisdictions where we have not obtained patents to develop their
own products and further, may export otherwise infringing products to territories where we have patents, but enforcement is not as strong
as that in the United States and Switzerland.

Many companies have
encountered significant problems in protecting and defending intellectual property in foreign jurisdictions. The legal systems of
certain countries, particularly China and certain other developing countries, do not favor the enforcement of patents, trade secrets
and other intellectual property, particularly those relating to medical devices and biopharmaceutical and biotechnology products,
which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our
proprietary rights generally. To date, we have not sought to enforce any issued patents in these foreign jurisdictions. Proceedings
to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from
other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent
applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits
that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. The requirements for
patentability may differ in certain countries, particularly developing countries. Certain countries in Europe and developing
countries, including China and India, have compulsory licensing laws under which a patent owner may be compelled to grant licenses
to third parties. In those countries, we and our licensors may have limited remedies if patents are infringed or if we or our
licensors are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could
limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may
be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.

If we are unable to maintain effective proprietary
rights for our product candidates, we may not be able to compete effectively in our markets.

In addition to the protection
afforded by any patents currently issued, historically, we have relied on trade secret protection and confidentiality agreements to protect
proprietary know-how that